(Reuters) – The Pfizer Inc/BioNTech SE COVID-19 vaccine was 93% effective in preventing hospitalizations among those aged 12 to 18,
Pfizer/BioNTech COVID-19 Vaccine Highly Protective in 12-18 Age Group – U.S. CDC Study

besthealthtale.com
Home »
(Reuters) – The Pfizer Inc/BioNTech SE COVID-19 vaccine was 93% effective in preventing hospitalizations among those aged 12 to 18,
(HealthDay)—Moderna Inc. announced Wednesday that it has completed its submission for full approval of its COVID-19 vaccine, while Pfizer Inc.